Sharekhan

Rallis India Ltd

Wed 30/04/2025,15:59:24 | NSE : RALLIS

₹ 235.26-2.59 (-1.09%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 235.00

Previous Close

₹ 237.85

Volume

391439

Mkt Cap ( Rs. Cr)

₹4575.08

High

₹ 244.70

Low

₹ 234.00

52 Week High

₹ 378.70

52 Week Low

₹ 196.00

Book Value Per Share

₹ 98.96

Dividend Yield

1.06

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Rallis India Ltd

Your Vote -

Buy

62.28%

Hold

33.53%

Sell

4.19%

62.28%

167 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

235.26

85

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

85

Option Chain

Analyzes market sentiment, predicts Rallis India Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Rallis India - Disclosure Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2

    30 Apr 2025, 11:11AM Disclosure under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Rallis India - Analysts/Institutional Investor Meet/Con. Call Updates

    29 Apr 2025, 10:27PM Rallis India Limited has informed the Exchange about Transcript
  • Rallis India - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    29 Apr 2025, 10:25PM Further to our letter dated April 9, 2025, we enclose herewith a copy of the transcript of the Analysts/Investors Call on the Audited financial result
  • Rallis India - Copy of Newspaper Publication

    25 Apr 2025, 1:39PM Rallis India Limited has informed the Exchange about Copy of Newspaper Publication
  • Rallis India - Analysts/Institutional Investor Meet/Con. Call Updates

    24 Apr 2025, 7:34PM Rallis India Limited has informed the Exchange about Link of Recording
  • Rallis India - Audio Recording Of Analysts/Investors Call Pertaining To The Audited Financial Results For The Quarter And Fin

    24 Apr 2025, 7:33PM Please find enclosed the link to the Audio recording of the Analysts/ Investors Call on the Audited Financial Results of the Company for the quarter a
  • Rallis India - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    23 Apr 2025, 10:14PM RALLIS INDIA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
  • Rallis India - Outcome of Board Meeting-XBRL

    23 Apr 2025, 9:36PM RALLIS INDIA LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 23-Apr-2025 for Dividend
  • Rallis India - Announcement under Regulation 30 (LODR)-Investor Presentation

    23 Apr 2025, 8:38PM Further to our letter dated April 9, 2025, enclosed in the presentation on the results for the quarter and financial year ended March 31, 2025 for the
  • Rallis India - Investor Presentation

    23 Apr 2025, 8:23PM Rallis India Limited has informed the Exchange about Investor Presentation
  • Rallis India - Press Release

    23 Apr 2025, 8:13PM Rallis India Limited has informed the Exchange regarding a press release dated April 23, 2025, titled ""Audited Financial Results of the Company for t
  • Rallis India - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    23 Apr 2025, 8:13PM Pursuant to Regulation 30 of SEBI Listing Regulations, enclosed herewith is a Copy of the Press Release with regard to the Audited Financial Results o
  • Rallis India - Appointment Of Secretarial Auditors Of The Company

    23 Apr 2025, 8:07PM Appointment of Secretarial Auditors of the Company
  • Rallis India - General Updates

    23 Apr 2025, 8:02PM Rallis India Limited has informed the Exchange about the appointment Secretarial Auditors of the Company
  • Rallis India - Announcement under Regulation 30 (LODR)-Change in Management

    23 Apr 2025, 8:02PM Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform you of the changes in Senior Management Personnel approved by the Board o
  • Rallis India - Announcement under Regulation 30 (LODR)-Change in Management

    23 Apr 2025, 7:56PM Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform that the Board of Directors at its Meeting held today, has relieved Mr. S
  • Rallis India - Change in Management

    23 Apr 2025, 7:51PM Rallis India Limited has informed the Exchange about change in Management
  • Rallis India - Appointment of Company Secretary and Compliance Officer

    23 Apr 2025, 7:47PM Based on the recommendation of Nomination and Remuneration Committee, the Board of directors, at its meeting held today, have appointed Ms. Sariga P.
  • Rallis India - Change in Company Secretary/Compliance Officer

    23 Apr 2025, 7:41PM Rallis India Limited has informed the Exchange about Change in Company Secretary/Compliance Officer
  • Rallis India - Corporate Action-Board approves Dividend

    23 Apr 2025, 7:35PM Pursuant to Regulation 30 of the SEBI Listing Regulations, the Board has recommended a dividend of Rs. 2.50 per share i.e. 250% for the financial year
  • Rallis India posts Q4 net loss of Rs 32.00 cr

    23 Apr 2025, 7:30PM The company reported standalone net loss during the quarter stood at Rs 32.00 crore as compared to net loss of Rs 21.00 crore in the previous year qua
  • Rallis India - Dividend

    23 Apr 2025, 7:26PM Rallis India Limited has informed the Exchange that Board of Directors at its meeting held on April 23, 2025, recommended Final Dividend of Rs. 2.5 pe
  • Rallis India - Audited Financial Results For The Quarter And Financial Year Ended March 31, 2025

    23 Apr 2025, 7:25PM Outcome of the board meeting dated April 23, 2025
  • Rallis India - Outcome of Board Meeting

    23 Apr 2025, 7:22PM Rallis India Limited has informed the Exchange regarding Outcome of Board Meeting held on April 23, 2025.
  • Rallis India - Board Meeting Outcome for - April 23, 2025

    23 Apr 2025, 7:13PM Outcome of the Board Meeting dated April 23, 2025
  • Rallis India has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    19 Apr 2025, 9:20PM As of March 2025, 55.08% is owned by Indian Promoters and 44.92% by Public. <p align=justify> Institutional holds 25.19% (Insurance Companies 1.10%) a
  • Rallis India - Change In Contact Details Of MUFG Intime India Private Limited, Registrar And Share Transfer Agent ('RTA') Of

    18 Apr 2025, 6:20PM Change in contact details of MUFG Intime India Private Limited, Registrar and Share Transfer Agent ('RTA') of the Company
  • Rallis India - Updates

    18 Apr 2025, 6:15PM Rallis India Limited has informed the Exchange regarding 'change in contact details of MUFG Intime India Private Limited, Registrar and Share Transfer
  • Rallis India - Analysts/Institutional Investor Meet/Con. Call Updates

    9 Apr 2025, 11:15PM Rallis India Limited has informed the Exchange about Schedule of meet
  • Rallis India - Board Meeting Intimation

    9 Apr 2025, 11:06PM RALLIS INDIA LIMITED has informed the Exchange about Board Meeting to be held on 23-Apr-2025 to consider and approve the Yearly Audited Financial resu
  • Rallis India - Copy of Newspaper Publication

    9 Apr 2025, 4:46PM Rallis India Limited has informed the Exchange about Copy of Newspaper Publication
  • Rallis India - Reminder Letter For Transfer Of Shares To Investor Education And Protection Fund (IEPF)

    8 Apr 2025, 11:14PM Enclosed is the specimen of letter sent to the shareholders whose shares are liable to be transferred to IEPF
  • Rallis India - General Updates

    8 Apr 2025, 11:08PM Rallis India Limited has informed the Exchange regarding 'Reminder Letter for transfer of shares to Investor Education and Protection Fund (IEPF)'
  • Rallis India - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Apr 2025, 4:27PM Rallis India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Rallis India - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Apr 2025, 4:34PM This is to certify that the details of securities dematerialised / rematerialised during the aforesaid period, as required under Regulation 74(5) of
  • Rallis India - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    1 Apr 2025, 10:58AM RALLIS INDIA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
  • Rallis India - Change in Management

    1 Apr 2025, 10:48AM Rallis India Limited has informed the Exchange about change in Management
  • Rallis India - Announcement under Regulation 30 (LODR)-Change in Management

    1 Apr 2025, 10:52AM Change in Senior Management Personnel of the Company
  • Rallis India - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    20 Mar 2025, 10:58AM RALLIS INDIA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
  • Rallis India - Change in Management

    20 Mar 2025, 10:56AM Rallis India Limited has informed the Exchange about change in Management
  • Rallis India - Announcement under Regulation 30 (LODR)-Change in Management

    20 Mar 2025, 10:50AM Change in Senior Management Personnel of the Company
  • Rallis India - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Mar 2025, 6:53PM Rallis India Limited has informed the Exchange about Schedule of meet
  • Rallis India - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    11 Mar 2025, 6:50PM This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.\r\nIn accordance with the said
  • Rallis India - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    11 Mar 2025, 6:36PM RALLIS INDIA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
  • Rallis India - Announcement under Regulation 30 (LODR)-Change in Management

    11 Mar 2025, 6:26PM Change in Senior Management Personnel of the Company
  • Rallis India - Change in Management

    11 Mar 2025, 6:24PM Rallis India Limited has informed the Exchange about change in Management
  • Rallis India - Outcome of Board Meeting

    11 Mar 2025, 6:05PM Rallis India Limited has informed the Exchange regarding Board meeting held on March 11, 2025.
  • Rallis India - Board Meeting Outcome for Outcome Of Board Meeting

    11 Mar 2025, 6:03PM Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform you of the changes in the Senior Management Personnel as approved by the
  • Rallis India - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    6 Mar 2025, 9:14PM RALLIS INDIA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
  • Rallis India - Change in Management

    6 Mar 2025, 9:10PM Rallis India Limited has informed the Exchange about change in Management
  • Rallis India - Announcement under Regulation 30 (LODR)-Change in Management

    6 Mar 2025, 9:01PM Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform you of the change in Senior Management Personnel
  • Rallis India - Product launch

    6 Mar 2025, 8:47PM Rallis India Limited has informed the Exchange about Product launch
  • Rallis India - Intimation Of Product Launch Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Reg

    6 Mar 2025, 8:40PM Pursuant to Regulation 30 read with Schedule III Part A Para B of the SEBI Listing Regulations, we wish to inform that Company has launched a new prod
  • Rallis India - Investor Presentation

    27 Feb 2025, 7:40AM Rallis India Limited has informed the Exchange about Investor Presentation
  • Rallis India - Analysts/Institutional Investor Meet/Con. Call Updates

    24 Feb 2025, 3:38PM Rallis India Limited has informed the Exchange about Schedule of meet
  • Rallis India - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    24 Feb 2025, 3:43PM This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.\r\n\r\nIn accordance with the
  • Rallis India - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Feb 2025, 8:11PM Rallis India Limited has informed the Exchange about Schedule of meet
  • Rallis India - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Feb 2025, 8:07PM This is in furtherance to our intimation dated January 24, 2025, to the Stock Exchanges regarding Analyst/ Institutional Investor Meetings.\r\n\r\nPle
  • Rallis India - Press Release

    3 Feb 2025, 8:02PM Rallis India Limited has informed the Exchange regarding a press release dated February 03, 2025, titled ""Rallis India gets Excellence in Business Re
  • Rallis India - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    3 Feb 2025, 7:52PM Enclosed herewith is a Press Release titled- 'Rallis India gets Excellence in Business Responsibility and Sustainability Reporting (BRSR) Award'
  • Tata Chemicals acquires 4.99% stake in Rallis India

    18 Jul 2023 , 10:24AM Tata Chemicals acquires 97 lakh shares of arm Rallis India at Rs. 215.05/sh via block
  • Rallis India

    20 Oct 2020 , 11:07AM Rallis India Q2FY21 result: Revenues/EBITDA at Rs725 crore/Rs117 crore, down 3.2%/1.6% y-o-y and substantially lower than street estimate by 10%/16%. The weak revenue performance was on the account of weaker-than-expected export revenues (down 29% y-o-y) while EBITDA margin at 16.1% (up marginally by 26bps y-o-y but lower than street estimates of 17.2%) was impacted by pricing pressure in international business and weak contract manufacturing business. The domestic crop care revenues grew by 8% y-o-y. Adjusted PAT at Rs82 crore (down 3.7% y-o-y) was also 15% below consensus estimate. Overall weak quarter given miss in revenues and EBITDA margin.
  • Rallis India

    23 Jul 2020 , 10:29AM Rallis India Q1FY2021 Results – Good quarter
  • Rallis India gains as Jhunjhunwala hikes stake

    20 Jul 2020 , 12:24PM Rallis India rises by 5% to Rs. 300.50, after Rakesh Jhunjhunwala hikes stake by 0.38 basis points
  • Rallis India

    10 Jul 2020 , 11:17AM The company has stated that it has merged its wholly owned subsidiary Zero Waste Organics into the company from 9th July 2020 after receiving all the necessary approvals.
  • Rallis India up in weak market

    4 May 2020 , 12:50PM Rakesh Jhunjhunwala ups stake in Rallis India
  • Rallis India reports stable performance

    24 Oct 2018 , 11:02AM Rallis India reported stable performance (Sep is typically the best quarter) during Q2FY18 with revenues witnessing a growth of 11.8% YoY to Rs 613 crores, EBITDA increased marginally by 1.8% YoY to Rs 129 crores, however margin was impacted by 200 bps to 21.1%. Net profit grew by 6.1% YoY to Rs 87 crores.
  • Rallis reports strong set of Q1FY19 results

    18 Jul 2018 , 12:38PM Rallis India reports strong set of Q1FY19 results with revenues being up by 30% YoY to Rs 573 crores
  • Rallis India gains after Franklin Templeton MF buys stake

    28 Nov 2017 , 12:03PM Rallis India gains after Franklin Templeton MF buys stake
  • Rallis India: Q2FY18 Healthy results led by better product mix and cost control measures

    25 Oct 2017 , 8:58AM Rallis reported healthy results for 2QFY18. Consolidate revenues stood at Rs 588cr (+9.1% YoY, +32.0% QoQ).

Key fundamentals

Evaluate the intrinsic value of Rallis India Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1905 1831.04 1833.8454 1754.6028 1629.2034
Liabilities 1905 1831.04 1833.8454 1754.6028 1629.2034
Equity 19 19.45 19.4471 19.4471 19.4471
Gross Profit 286 311.15 218.3397 274.1404 322.9867
Net Profit 125 147.87 91.9436 164.2742 228.6653
Cash From Operating Activities 295 269.07 216.8243 165.8518 216.2403
NPM(%) 4.69 5.58 3.09 6.3 9.41
Revenue 2663 2648.38 2966.9747 2603.9337 2429.4349
Expenses 2377 2337.23 2748.635 2329.7933 2106.4482
ROE(%) 6.49 7.68 4.77 8.53 11.88

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
2.5 250 1.06 253.89
03 Jun 2024 2.5 250 1.06 282.45
30 May 2023 2.5 250 1.06 199.2
06 Jun 2022 3 300 1.06 281.45
09 Jun 2021 3 300 1.06 281.6
17 Jun 2020 2.5 250 1.06 223.75
19 Jun 2019 2.5 250 1.06 157.8
19 Jun 2018 2.5 250 1.06 233.95
0 0 1.06 240.5
09 Jun 2017 2.5 250 1.06 239.75
09 Jun 2017 1.25 125 1.06 251.3
10 Jun 2016 2.5 250 1.06 193.2
12 Jun 2015 1.5 150 1.06 222.3
29 Oct 2014 1 100 1.06 226.4
13 Jun 2014 1.4 140 1.06 180.2
30 Oct 2013 1 100 1.06 159.2
07 Jun 2013 1.3 130 1.06 123.05
29 Oct 2012 1 100 1.06 141.1
11 Jun 2012 1.2 120 1.06 128.45
01 Nov 2011 1 100 1.06 172.4
08 Jun 2011 11 110 1.06 1490.4
28 Oct 2010 9 90 1.06 1426.6
03 May 2010 10 100 1.06 1428.05
29 Oct 2009 8 80 1.06 985.15
12 May 2009 16 160 1.06 529.25
13 May 2008 16 160 1.06 434
09 May 2007 8 80 1.06 262.4
12 May 2006 4 40 1.06 318.4
15 Jun 2005 1 10 1.06 260.95
22 Aug 2002 0 100 1.06 126.15
0 0 1.06 63.1
0 60 1.06 94.95
0 60 1.06 148.5
0 50 1.06 105.5
0 45 1.06 172.75

Peers

Other companies within the same industry or sector that are comparable to Rallis India Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 550.40 -0.26 20.33 2121.54 35.34 0.55
Amines and Plasticizers Ltd 208.34 -2.37 27.85 1293.80 361.94 0.24
Grauer and Weil (India) Ltd 115.60 0.00 32.66 5330.99 322.62 0.43
HP Adhesives Ltd 52.53 -1.41 24.66 2160.43 111.94 0.00

Company Info

YEAR EVENTS 1948 - The Company was incorporated on 23rd August, at Calcutta. The Company manufacture and sell pharmaceuticals, super phosphate, fertiliser mixtures, pesticides, hydrosulphite of soda, electric fans, petrol fans, petrol engines and garments and also to trade in fertiliser, cotton, tanning materials, piece goods, textiles, crushed bones and marine products. The Company had distribution arrangements for single and compound fertilisers, electric fans, stationary and portable machine tools, electrical appliances, power sprayers, pharmaceuticals, chemicals, and household products. Rallis Brothers Ltd., was incorporated in West Bengal to carry on business in India. - 75,000 Pref. Shares and 92,095 No. of equity shares issued to Ralli Bros. Ltd. 405 No. of equity shares to director and signatories to Memorandum of Association. 1,32,500 No. of equity shares issued to Ralli Bros. Ltd. on consideration of assets taken over from them. 1951 - 65,000 Pref. and 1,15,000 No. of equity shares (prem. Rs 15 per share) offered for sale by Ralli Brothers, Ltd., to the Indian public. 1958 - The Company acquired the enterprise of Teddington Chemical Factory (P) Ltd. 1961 - Reddington Chemicals was merged with the Company. 1971 - Effective from 1st January, the Company negotiated the acquisition of assets of James & Co., a proprietary concern engaged in the canning of food under trade name SIL. 1972 - Tata Fison Industries, Ltd., was amalgamated with the Company with effect from 1st September. The shareholders of Tata Fison were allotted 3 fully paid-up Equity shares against 4 fully paid-up Equity shares, and 3 fully paid-up Equity shares plus 3 fractional certificates representing one tenth Equity shares against eight, Rs 55 paid-up Equity shares. The Company's subsidiary Rallifan, Ltd. was merged with it with effect from 31st August, 1966. 1973 - Since September, the Company became a subsidiary of Rallis India, Ltd. This was amalgamated with the Company effective from 30th June, 1987. - 93,000 No. of equity shares issued as fully paid-up to shareholders of Tata Fison Industries, Ltd. pursuant to the Scheme of Amalgamation. 1976 - 63,600 Right Equity shares issued in prop. 1:3 at a premium of Rs 25 per share on 5th January. 31 Right Equity shares forfeited. 1,14,470 Bonus Equity shares issued in prop. 3:10. 1978 - The subsidiary Ralli Chemicals Ltd. was merged with the Company with effect from 1st September. 1981 - With effect from 1st September, Whilfens (India), Ltd. was amalgamated with the Company. The shareholders of Whilfens were allotted 18,473 No. of equity shares of the Company in the proportion of 1 Ralli share of Rs 100 each for every 6 No. of equity shares of Rs 10 each held in Whilfen. - 33,331 shares allotted to Financial Institutions as part conversion of their loans. (8,333 to ICICI, 8,333 to UTI and 8,332 to GIC and its subsidiaries) and 18,473 shares allotted to erstwhile shareholders of Whilfens (India) Ltd., which was amalgamated with the Company. 1982 - The Company acquired 2,10,286 No. of equity shares of Rs 10 each of Protein Products of India, Ltd. which was deemed a Government Company pursuant to Section 619 B of the Company's Act. The Company along with its subsidiaries - W.T. Surin & Co., Ltd., Ralli Machines Ltd., and Ralliwolf, Ltd. held 60% of the equity capital of Protein Products of India, Ltd (PPI). Hence, PPI became a subsidiary of the company. 1983 - Protein Products of India, Ltd., which manufactures gelatine, ossein and di-calcium phosphate, was merged with the Company with effect from 1st September. The merger became effective on 17th March, 1986. 1985 - 16,441 No. of equity shares allotted without payment in cash to the Protein Products of India, Ltd. on its merger with the Company. 1986 - The Plants for the manufacture of two new pesticides were commissioned at Ankleshwar. - The Company issued 3,95,000 - 13.5% secured redeemable partly convertible debentures of Rs 500 each during the year. Out of the total issue, 18,811 debentures were offered to the employees of the Company and the balance of 3,76,189 debentures were offered to the existing equity shareholders in the proportion of 2 debentures to 3 equity shares held. Out of the employees' quota, only 11,834 debentures were taken up while the offer for shareholders was over-subscribed. Thus, a total of 3,88,023 debentures were allotted on 1st May, 1987. - Pursuant to the terms of the issue of debentures, the Convertible portion of Rs 250 out of each debenture was compulsorily and automatically converted into 10 equity shares of Rs 10 each of the Company at a premium of Rs 15 per share effective from 1st November, 1987. - The Non-convertible portion of Rs 250 out of each debenture bearing interest at 13.5% per annum would be redeemed on maturity on 30th April, 1997. - The Company cancelled its 75,000 - 6% preference shares of Rs 100 each on 1st June, and in lieu thereof allotted 75,000 - 15% non-convertible debentures of Rs 100 each to the erstwhile preference shareholders. 1987 - A modern bulk drug plant was commissioned at Ankleshwar to manufacture new drugs. - Plans for the manufacture of three new pesticides were commissioned and implementation of a fully export-oriented basic chemical manufacturing facility was in progress. - Ralli Machines Ltd. (RML), a subsidiary of the Company was amalgamated with the Company with effect from 1st June. 1988 - The Agrochemicals division launched four new products during the period. The Research and Development centre of the agrochemicals division set up a comprehensive toxicological laboratory at Bangalore. 1989 - The agro chemicals division completed and commissioned new facilities for the manufacture of Acephate and Cypermethrin. New facilities were set up for export oriented fungicides and achieved a two-fold expansion of productions of Captafol. In addition, a new facility for an intermediate required in the production of Fenvalerate was set up and commissioned. - 7,627 No. of Equity shares allotted without payment in cash to shareholders of Rallis Machines, Ltd., on its merger. 1990 - With considerable expertise gained in the designing and commissioning of chemical plants, the agro chemicals division entered the field of project exports. - At the meeting held on 21st November, the Company decided to dispose of the Engineering undertakings as well as the Company's direct and indirect shareholders in the Engineering subsidiaries Ralli Wolf Ltd. and the Indian Standard Metal Co., Ltd. 1991 - The Agro chemicals unit signed a turnkey contract with the National Petrochemical Company of Iran for a 2500 TPA/500 TPA. - A new facility for parenterals was put into operation at Aurangabad. The pharmaceutical division diversified into Ayurvedic products range. - In term of the orders of the High Courts at Mumbai and Ahmedabad dated 4.5.1991 and 13.5.1991, Accumax Ltd. was merged with the Company on 26.6.1991 with retrospective effect from 1.1.1988. As per the terms of the merger, 60,800 shares of Rs 10 each were allotted to the shareholders of Accumax, Ltd. - Ahura Consultants & Investments Ltd. (Ahura), a subsidiary of the Company was amalgamated with the Company with effect from 1st April. - The Company offered 11,91,337 - 12.5% secured partly convertible debentures of Rs 160 each on Rights basis in the proportion 1 debentures: 8 equity shares held (All were taken up). - Another 59,570-12.5% debentures were issued to the employees on an equitable basis (only 5,211 debentures taken up). The unsubscribed portion of 54,359 debentures was allowed to lapse. Rs 80 of the face value of each debenture was to be converted into 2 equity shares of Rs 10 each at a premium of Rs 30 per share on the expiry of 6 months from the date of allotment of debentures. Remaining Rs 80 of the face value of each debenture was to be redeemed at par on the expiry of 10 years from the date of allotment of debentures. - 23,93,096 shares allotted (prem. Rs 30 per share) on part conversion 12.5% partly convertible debentures on 19.2.1992. 1992 - Tata Tea Ltd. (TTL) proposed to make an offer to the resident Indian equity shareholders of the Company to acquire upto 24.99% of the existing equity share capital of the Company. 1993 - The Company proposed to enter real estate development business. 1995 - The agrochemicals division performed well and the unit introduced a range of other agro products as an input-supply agency. The performance of pharmaceutical division affected due to non-availability of Dextran products. Production of fine chemicals was affected due to non-availability of raw materials such as hydrochlorine and, bones etc. 1996 - The pharmaceutical division registered an impressive performance and new products were introduced. - 350,00,000 pref. shares allotted as private placement basis and they would be redeemed at the end of 3 years from the date of allotment i.e. on 28.2.2000 & 30.3.2000 with pvt. & call option at the end of 2 years. 1997 - Three new high margin products introduced during the year contributed to the success of the division. Gelatine business was affected. The leather chemicals business introduced a new range of finishing chemicals in collaboration with a U.K. Company. Further expansion was planned in collaboration with a Dutch company and with their support it was proposed to introduce a range of high quality fat liquors. - British drug group Phytopharm Plc said on November 3 it had signed a long-term agreement with Rallis India Ltd to develop products based on medicinal plant extracts. - Rallis is part of India's Tata Group, the country's largest business conglomerate. - Rallis is the largest agro-business company and the second largest seed producer in India. - Rallies has successfully introduced quality hybrid seeds in collaboration with Cargill Seeds of USA and Bejo Zaden, Holland. 1998 - Rallis India has forged a marketing alliance with the world's largest producer of fertilisers, Norsk Hydro of Netherlands, to market speciality fertilisers. - ICRA has assigned an `A1 ' rating to the Rs.10 crore commercial paper programme of Rallis (India) Ltd (RIL). The rating indicates highest safety. - The company has recently entered into separate licencing agreements with Switzerland-based pharma company Geisltch, and Netherlands-based Euro Drug. - The company has proposed to convert one of its existing pesticide units for producing special grade polymers for fabricating interiors of aircraft. - Rallis has also become the first Indian company to isolate a gene construct which marks the company's entry into the realms of genetically-engineered plants. - Rallis has also recently become only the second producer in the world, and the first in India, of pendimethylene, the world's number two herbicide. - The company has developed a 600 acre farm near Nashik in Maharashtra with technical collaboration from Mitsubishi Corporation of Japan. 1999 - The company has been working closely with sericulturists and farmers in an attempt to develop the venture. The company is also introducing international irrigation and sericulture techniques to improve yields, and productivity. - Tata group agrochemical major Rallis India has set up a new company called Rallis Farm Management to provide advisory and technical services in the agri sector. - Rallis had recently set up a new company -- called Rallis Farm Management -- to provide advisory and technical services in the agricultural sector. - Rallis India Ltd. and American multinational Monsanto have signed a memorandum of understanding (MoU) to jointly develop and launch rural-development initiatives in India. - Rallis India has entered into a pact with the $4.5bn FMC Ltd, the fifth-largest agrochemical producer in the world, under which it will formulate some of FMC's products in India. The agreement, signed on August 6, extends a relationship which Rallis already has with FMC for a few other products. - The rating agency, Icra, has downgraded the rating assigned to the Rs 5 crore non-convertible debenture (NCD) programme of Mold-Tek Plastics Ltd (MPL) from `LA ' to `LBBB ' indicating moderate safety. 2000 - Tata Metaliks managing director Rajeev Dubey will take charge as chief executive officer of the Rs 1,256-crore Rallis India. - Tata group company, has decided to pull out of its agrochemical joint venture with FMC Corporation citing restructuring within the overall Tata group and recent changes in the global agrochemical market. -Rallis India, country's largest agrichemicals company, has tied up with the UK-based fertiliser giant Borax Europe to market Solubor in India in line with the company's strategy to market foreign companies products. -Launching an interactive Website called rallikisan.com -Sanat Products Limited (SPL) in which Dabur India holds 30 per cent equity stake has signed a marketing tie-up with the Tata group company Rallis India for distribution of its herbal OTC (over-the-counter) products in Africa and Sri Lanka. -Obtained a sanction for a Rs 50-crore term loan from ICICI Ltd 2001 -Mr. R Gopalakrishnan, a director of Rallis India, has been appointed its vice-chairman. Gopalakrishnan is an executive director of Tata Sons and is a member of the group executive office of the Tata Group. -Sells its pharmaceutical business to Shreya Impex, part of Moscow-based Shreya Corporation, for Rs 49 crore. -Approves the merger of its wholly-owned subsidiaries with the company. The subsidiaries are Ralchem Ltd, Rallis Finance & Investments Co Ltd, -Kicks off a downsizing exercise for reducing employees at the managerial level. Around 200-odd managers opt for an early separation scheme started by the company in April 15, 2001 -Fire breaks out at the Rallis Ankleshwar Plant Unit II. Seven workers sustain burn injuries. Leakage of inflammable gas from a fractioning column of a unit manufacturing intermediate chemical CMAC used for manufacture of Cypermethrin, appeared to be the cause of the fire. -Launched its Web site, called www.rallis.co.in -Sells its surplus land at Andheri, a Mumbai suburb, to Tata Consultancy Services (TCS) for Rs 133 crore -Approves merger of its wholly owned subsidiaries i.e. Rallis Finance and Investments Ltd., Rallis Farm Management Services Ltd., Rallis Hybrid Seeds Ltd., Ralchem Ltd. and Sankhya Garments Ltd with the company. 2002 -Closes down four of its manufacturing units.The shut down four companies are Siris India's unit (a loss making subsidiary of Rallis India), Ralchem Ltd's second unit in Ankleshwar, a tanning and an agrochemicals unit at Ankleshwar. -Enters into a new contract farming agreement with State Bank of India, ending its earlier agreement with ICICI Bank -Mr. Rajeev Dubey, CEO & Executive Director of the company, redesignated as Managing Director w.e.f.July 29, 2002 -Tata Chemicals Ltd. issues termination notice to the company in respect of the marketing arrangement for urea -Shareholders approve the Scheme of Amalgamation of its 5 subsidiaries (Rallis Finance and Investments Company Ltd., Rallis Farm Management Services Ltd, Rallis Hybrid Seeds Ltd, Ralchem Ltd and Sankhya Garments Ltd with the Company) 2003 - Forges an alliance with Kureha Chemical Ltd, a leading Japanese company, for Metconazole fungicide plant -Approves the merger of Siris India Ltd., a wholly owned subsidiary of the company, with Rallis India Ltd. -Mr. Rajeev Dubey resigs as Managing Director -Dr. Venkatrao Sohoni appointed as Managing Director of the company w.e.f. August 11, 2003. -Offers VRS to its staff -Mrs. Shirin V. Balsara has resigned as Director (Legal) & Company Secretary of the Company w.e.f. September 20, 2003 -Aproves the sale of Rallis House to Tata Consultancy Services Ltd for a total consideration of Rs 560 million -The Lok Prakashan Ltd. acquires 6,68,396 equity shares (constituting 5.58% of the paid-up equity share capital of the Company) -Registered office of the company changed from Ralli House, 21, D.S.Marg, Mumbai - 400 001 to 7th Floor, Apeejay House, 3, Dinshaw Vachha Road, Churchgate, Mumbai 400 020. 2004 -Board of the company decides to issue, on a private placement basis, 9,00,00,000, 7.5 % Cumulative Redeemable Preference Shares of Rs 10/- each, aggregating to Rs 900 million. The said issue shall open from January 2, 2004 to January 31, 2004 -Rallis India sells gelatine biz to Sterling Biotech Ltd -Rallis India inks pact with Dupont India Pvt Ltd on April 5, 2004, for insecticide marketing -Rallis India Ltd has informed that the company and EI Dupont India Private Ltd on April 5, 2004 have entered into an agreement, whereby company will co-market Dupont's insecticide Indoxacarb and Dupont will co-market company's insecticide Acetamiprid. - Rallis India enters into marketing alliances with global players like Syngenta, Bayer and Dupont 2007 -Rallis India Ltd has appointed Mr. Veeramani Shankar as the Executive Director of the Company. 2008 - Rallis India Ltd has informed that Dr. V S Sohoni has been appointed as Additional Director on the Board of the Company with effect from March 01, 2008. 2009 - Rallis India Ltd has appointed Mr. R. Mukundan as Additional Director on the Board of the Company. --Registered Office of the Company has been shifted to 156/157, 15th Floor, Nariman Bhavan, 227, Nariman Point, Mumbai - 400 021 2010 - Company has inaugurated a new Metconazole plant at its factory in Ankleshwar, Gujarat - Rallis India Ltd Acquires Majority stake in Metahelix Life Sciences - Rallis India - Board approves Bonus Issue -Rallis India has given the Bonus in the Ratio of 1:2 2011 - Rallis India crosses sales figure of Rs 1,000 crore For the year ended March 31, 2011 - Company has commenced commercial production at its new manufacturing facility at Dahej SEZ, Gujarat. -Company has splits its Face value of Shares from Rs 10 to Re 1 2012 - Rallis India Acquires 22.8% Stake in Zero Waste Agro Organics Private Limited 2013 - Tata Quality Management Services awarded Company's Dahej unit under Promising Innovations Category for New Product Innovation - The Company received National Energy Conservation Award from Mr. Pranab Mukerjee (President of India) for winning under Chemical sector -The Company awarded as Winner of Golden Peacock Award for Eco-Innovation in Chemical Sector - Federation of Indian Chambers of Commerce & Industry (FICCI) awarded the Company as Product Innovator of the Year in Agro Sector -The Company has recommended final dividend of Rs. 1.30 per share (130%) to the shareholders of the Company. 2014 - Rallis India Ltd appointed Dr. Punita Kumar-Sinha as an Additional Non - Executive, Independent Director of the Company - The Company has recommended final dividend of Rs. 1.40 per share (140%) to the shareholders of the Company. - ICC awarded Certificate of Merit for Best Compliant Company for the Process Safety Code under Responsible Care - Dahej unit awarded National Safety Award - The Award was presented by Hon'ble Union Minister for Labour & Employment Shri Narendra Singh Tomar at Vigyan Bhavan, New Delhi 2015 -India's Most Trusted Brand Award, 2015 in Best Company category -CII EXIM prize for Business Excellence -Origin product has received Product Innovator of the Year in Agrochemicals Sector awarded by FICCI Chemicals & Petrochemicals Awards 2016 -Rallis India gets approval for Rs 200 cr project in Gujarat. -The Company has signed an Agreement for increasing its stake in its Subsidiary Zero Waste Agro - Organics Limited from 73.63% to 100%. Consequently, ZWAO and become a wholly owned subsidiary of the Company, on completion of the acquisition of the balance shares in ZWAOL. 2019 -The Company has considered and approved the proposal for the merger of Metahelix Life Sciences Limited ('Transferor Company'), a wholly owned subsidiary of the Company, with Rallis India Limited ('the Company' or 'Transferee Company') and their Shareholders and Creditors, under Sections 230 to 234 of the Companies Act, 2013 2023 -"Rallis India powers its hybrid seed production process with mobile app SeedSure." 2024 -Rallis India Limited achieve key Flavocide production milestone.

YEAR EVENTS 1948 - The Company was incorporated on 23rd August, at Calcutta. The Company manufacture and sell pharmaceuticals, super phosphate, fertiliser mixtures, pesticides, hydrosulphite of soda, electric fans, petrol fans, petrol engines and garments and also to trade in fertiliser, cotton, tanning materials, piece goods, textiles, crushed bones and marine products. The Company had distribution arrangements for single and compound fertilisers, electric fans, stationary and portable machine tools, electrical appliances, power sprayers, pharmaceuticals, chemicals, and household products. Rallis Brothers Ltd., was incorporated in West Bengal to carry on business in India. - 75,000 Pref. Shares and 92,095 No. of equity shares issued to Ralli Bros. Ltd. 405 No. of equity shares to director and signatories to Memorandum of Association. 1,32,500 No. of equity shares issued to Ralli Bros. Ltd. on consideration of assets taken over from them. 1951 - 65,000 Pref. and 1,15,000 No. of equity shares (prem. Rs 15 per share) offered for sale by Ralli Brothers, Ltd., to the Indian public. 1958 - The Company acquired the enterprise of Teddington Chemical Factory (P) Ltd. 1961 - Reddington Chemicals was merged with the Company. 1971 - Effective from 1st January, the Company negotiated the acquisition of assets of James & Co., a proprietary concern engaged in the canning of food under trade name SIL. 1972 - Tata Fison Industries, Ltd., was amalgamated with the Company with effect from 1st September. The shareholders of Tata Fison were allotted 3 fully paid-up Equity shares against 4 fully paid-up Equity shares, and 3 fully paid-up Equity shares plus 3 fractional certificates representing one tenth Equity shares against eight, Rs 55 paid-up Equity shares. The Company's subsidiary Rallifan, Ltd. was merged with it with effect from 31st August, 1966. 1973 - Since September, the Company became a subsidiary of Rallis India, Ltd. This was amalgamated with the Company effective from 30th June, 1987. - 93,000 No. of equity shares issued as fully paid-up to shareholders of Tata Fison Industries, Ltd. pursuant to the Scheme of Amalgamation. 1976 - 63,600 Right Equity shares issued in prop. 1:3 at a premium of Rs 25 per share on 5th January. 31 Right Equity shares forfeited. 1,14,470 Bonus Equity shares issued in prop. 3:10. 1978 - The subsidiary Ralli Chemicals Ltd. was merged with the Company with effect from 1st September. 1981 - With effect from 1st September, Whilfens (India), Ltd. was amalgamated with the Company. The shareholders of Whilfens were allotted 18,473 No. of equity shares of the Company in the proportion of 1 Ralli share of Rs 100 each for every 6 No. of equity shares of Rs 10 each held in Whilfen. - 33,331 shares allotted to Financial Institutions as part conversion of their loans. (8,333 to ICICI, 8,333 to UTI and 8,332 to GIC and its subsidiaries) and 18,473 shares allotted to erstwhile shareholders of Whilfens (India) Ltd., which was amalgamated with the Company. 1982 - The Company acquired 2,10,286 No. of equity shares of Rs 10 each of Protein Products of India, Ltd. which was deemed a Government Company pursuant to Section 619 B of the Company's Act. The Company along with its subsidiaries - W.T. Surin & Co., Ltd., Ralli Machines Ltd., and Ralliwolf, Ltd. held 60% of the equity capital of Protein Products of India, Ltd (PPI). Hence, PPI became a subsidiary of the company. 1983 - Protein Products of India, Ltd., which manufactures gelatine, ossein and di-calcium phosphate, was merged with the Company with effect from 1st September. The merger became effective on 17th March, 1986. 1985 - 16,441 No. of equity shares allotted without payment in cash to the Protein Products of India, Ltd. on its merger with the Company. 1986 - The Plants for the manufacture of two new pesticides were commissioned at Ankleshwar. - The Company issued 3,95,000 - 13.5% secured redeemable partly convertible debentures of Rs 500 each during the year. Out of the total issue, 18,811 debentures were offered to the employees of the Company and the balance of 3,76,189 debentures were offered to the existing equity shareholders in the proportion of 2 debentures to 3 equity shares held. Out of the employees' quota, only 11,834 debentures were taken up while the offer for shareholders was over-subscribed. Thus, a total of 3,88,023 debentures were allotted on 1st May, 1987. - Pursuant to the terms of the issue of debentures, the Convertible portion of Rs 250 out of each debenture was compulsorily and automatically converted into 10 equity shares of Rs 10 each of the Company at a premium of Rs 15 per share effective from 1st November, 1987. - The Non-convertible portion of Rs 250 out of each debenture bearing interest at 13.5% per annum would be redeemed on maturity on 30th April, 1997. - The Company cancelled its 75,000 - 6% preference shares of Rs 100 each on 1st June, and in lieu thereof allotted 75,000 - 15% non-convertible debentures of Rs 100 each to the erstwhile preference shareholders. 1987 - A modern bulk drug plant was commissioned at Ankleshwar to manufacture new drugs. - Plans for the manufacture of three new pesticides were commissioned and implementation of a fully export-oriented basic chemical manufacturing facility was in progress. - Ralli Machines Ltd. (RML), a subsidiary of the Company was amalgamated with the Company with effect from 1st June. 1988 - The Agrochemicals division launched four new products during the period. The Research and Development centre of the agrochemicals division set up a comprehensive toxicological laboratory at Bangalore. 1989 - The agro chemicals division completed and commissioned new facilities for the manufacture of Acephate and Cypermethrin. New facilities were set up for export oriented fungicides and achieved a two-fold expansion of productions of Captafol. In addition, a new facility for an intermediate required in the production of Fenvalerate was set up and commissioned. - 7,627 No. of Equity shares allotted without payment in cash to shareholders of Rallis Machines, Ltd., on its merger. 1990 - With considerable expertise gained in the designing and commissioning of chemical plants, the agro chemicals division entered the field of project exports. - At the meeting held on 21st November, the Company decided to dispose of the Engineering undertakings as well as the Company's direct and indirect shareholders in the Engineering subsidiaries Ralli Wolf Ltd. and the Indian Standard Metal Co., Ltd. 1991 - The Agro chemicals unit signed a turnkey contract with the National Petrochemical Company of Iran for a 2500 TPA/500 TPA. - A new facility for parenterals was put into operation at Aurangabad. The pharmaceutical division diversified into Ayurvedic products range. - In term of the orders of the High Courts at Mumbai and Ahmedabad dated 4.5.1991 and 13.5.1991, Accumax Ltd. was merged with the Company on 26.6.1991 with retrospective effect from 1.1.1988. As per the terms of the merger, 60,800 shares of Rs 10 each were allotted to the shareholders of Accumax, Ltd. - Ahura Consultants & Investments Ltd. (Ahura), a subsidiary of the Company was amalgamated with the Company with effect from 1st April. - The Company offered 11,91,337 - 12.5% secured partly convertible debentures of Rs 160 each on Rights basis in the proportion 1 debentures: 8 equity shares held (All were taken up). - Another 59,570-12.5% debentures were issued to the employees on an equitable basis (only 5,211 debentures taken up). The unsubscribed portion of 54,359 debentures was allowed to lapse. Rs 80 of the face value of each debenture was to be converted into 2 equity shares of Rs 10 each at a premium of Rs 30 per share on the expiry of 6 months from the date of allotment of debentures. Remaining Rs 80 of the face value of each debenture was to be redeemed at par on the expiry of 10 years from the date of allotment of debentures. - 23,93,096 shares allotted (prem. Rs 30 per share) on part conversion 12.5% partly convertible debentures on 19.2.1992. 1992 - Tata Tea Ltd. (TTL) proposed to make an offer to the resident Indian equity shareholders of the Company to acquire upto 24.99% of the existing equity share capital of the Company. 1993 - The Company proposed to enter real estate development business. 1995 - The agrochemicals division performed well and the unit introduced a range of other agro products as an input-supply agency. The performance of pharmaceutical division affected due to non-availability of Dextran products. Production of fine chemicals was affected due to non-availability of raw materials such as hydrochlorine and, bones etc. 1996 - The pharmaceutical division registered an impressive performance and new products were introduced. - 350,00,000 pref. shares allotted as private placement basis and they would be redeemed at the end of 3 years from the date of allotment i.e. on 28.2.2000 & 30.3.2000 with pvt. & call option at the end of 2 years. 1997 - Three new high margin products introduced during the year contributed to the success of the division. Gelatine business was affected. The leather chemicals business introduced a new range of finishing chemicals in collaboration with a U.K. Company. Further expansion was planned in collaboration with a Dutch company and with their support it was proposed to introduce a range of high quality fat liquors. - British drug group Phytopharm Plc said on November 3 it had signed a long-term agreement with Rallis India Ltd to develop products based on medicinal plant extracts. - Rallis is part of India's Tata Group, the country's largest business conglomerate. - Rallis is the largest agro-business company and the second largest seed producer in India. - Rallies has successfully introduced quality hybrid seeds in collaboration with Cargill Seeds of USA and Bejo Zaden, Holland. 1998 - Rallis India has forged a marketing alliance with the world's largest producer of fertilisers, Norsk Hydro of Netherlands, to market speciality fertilisers. - ICRA has assigned an `A1 ' rating to the Rs.10 crore commercial paper programme of Rallis (India) Ltd (RIL). The rating indicates highest safety. - The company has recently entered into separate licencing agreements with Switzerland-based pharma company Geisltch, and Netherlands-based Euro Drug. - The company has proposed to convert one of its existing pesticide units for producing special grade polymers for fabricating interiors of aircraft. - Rallis has also become the first Indian company to isolate a gene construct which marks the company's entry into the realms of genetically-engineered plants. - Rallis has also recently become only the second producer in the world, and the first in India, of pendimethylene, the world's number two herbicide. - The company has developed a 600 acre farm near Nashik in Maharashtra with technical collaboration from Mitsubishi Corporation of Japan. 1999 - The company has been working closely with sericulturists and farmers in an attempt to develop the venture. The company is also introducing international irrigation and sericulture techniques to improve yields, and productivity. - Tata group agrochemical major Rallis India has set up a new company called Rallis Farm Management to provide advisory and technical services in the agri sector. - Rallis had recently set up a new company -- called Rallis Farm Management -- to provide advisory and technical services in the agricultural sector. - Rallis India Ltd. and American multinational Monsanto have signed a memorandum of understanding (MoU) to jointly develop and launch rural-development initiatives in India. - Rallis India has entered into a pact with the $4.5bn FMC Ltd, the fifth-largest agrochemical producer in the world, under which it will formulate some of FMC's products in India. The agreement, signed on August 6, extends a relationship which Rallis already has with FMC for a few other products. - The rating agency, Icra, has downgraded the rating assigned to the Rs 5 crore non-convertible debenture (NCD) programme of Mold-Tek Plastics Ltd (MPL) from `LA ' to `LBBB ' indicating moderate safety. 2000 - Tata Metaliks managing director Rajeev Dubey will take charge as chief executive officer of the Rs 1,256-crore Rallis India. - Tata group company, has decided to pull out of its agrochemical joint venture with FMC Corporation citing restructuring within the overall Tata group and recent changes in the global agrochemical market. -Rallis India, country's largest agrichemicals company, has tied up with the UK-based fertiliser giant Borax Europe to market Solubor in India in line with the company's strategy to market foreign companies products. -Launching an interactive Website called rallikisan.com -Sanat Products Limited (SPL) in which Dabur India holds 30 per cent equity stake has signed a marketing tie-up with the Tata group company Rallis India for distribution of its herbal OTC (over-the-counter) products in Africa and Sri Lanka. -Obtained a sanction for a Rs 50-crore term loan from ICICI Ltd 2001 -Mr. R Gopalakrishnan, a director of Rallis India, has been appointed its vice-chairman. Gopalakrishnan is an executive director of Tata Sons and is a member of the group executive office of the Tata Group. -Sells its pharmaceutical business to Shreya Impex, part of Moscow-based Shreya Corporation, for Rs 49 crore. -Approves the merger of its wholly-owned subsidiaries with the company. The subsidiaries are Ralchem Ltd, Rallis Finance & Investments Co Ltd, -Kicks off a downsizing exercise for reducing employees at the managerial level. Around 200-odd managers opt for an early separation scheme started by the company in April 15, 2001 -Fire breaks out at the Rallis Ankleshwar Plant Unit II. Seven workers sustain burn injuries. Leakage of inflammable gas from a fractioning column of a unit manufacturing intermediate chemical CMAC used for manufacture of Cypermethrin, appeared to be the cause of the fire. -Launched its Web site, called www.rallis.co.in -Sells its surplus land at Andheri, a Mumbai suburb, to Tata Consultancy Services (TCS) for Rs 133 crore -Approves merger of its wholly owned subsidiaries i.e. Rallis Finance and Investments Ltd., Rallis Farm Management Services Ltd., Rallis Hybrid Seeds Ltd., Ralchem Ltd. and Sankhya Garments Ltd with the company. 2002 -Closes down four of its manufacturing units.The shut down four companies are Siris India's unit (a loss making subsidiary of Rallis India), Ralchem Ltd's second unit in Ankleshwar, a tanning and an agrochemicals unit at Ankleshwar. -Enters into a new contract farming agreement with State Bank of India, ending its earlier agreement with ICICI Bank -Mr. Rajeev Dubey, CEO & Executive Director of the company, redesignated as Managing Director w.e.f.July 29, 2002 -Tata Chemicals Ltd. issues termination notice to the company in respect of the marketing arrangement for urea -Shareholders approve the Scheme of Amalgamation of its 5 subsidiaries (Rallis Finance and Investments Company Ltd., Rallis Farm Management Services Ltd, Rallis Hybrid Seeds Ltd, Ralchem Ltd and Sankhya Garments Ltd with the Company) 2003 - Forges an alliance with Kureha Chemical Ltd, a leading Japanese company, for Metconazole fungicide plant -Approves the merger of Siris India Ltd., a wholly owned subsidiary of the company, with Rallis India Ltd. -Mr. Rajeev Dubey resigs as Managing Director -Dr. Venkatrao Sohoni appointed as Managing Director of the company w.e.f. August 11, 2003. -Offers VRS to its staff -Mrs. Shirin V. Balsara has resigned as Director (Legal) & Company Secretary of the Company w.e.f. September 20, 2003 -Aproves the sale of Rallis House to Tata Consultancy Services Ltd for a total consideration of Rs 560 million -The Lok Prakashan Ltd. acquires 6,68,396 equity shares (constituting 5.58% of the paid-up equity share capital of the Company) -Registered office of the company changed from Ralli House, 21, D.S.Marg, Mumbai - 400 001 to 7th Floor, Apeejay House, 3, Dinshaw Vachha Road, Churchgate, Mumbai 400 020. 2004 -Board of the company decides to issue, on a private placement basis, 9,00,00,000, 7.5 % Cumulative Redeemable Preference Shares of Rs 10/- each, aggregating to Rs 900 million. The said issue shall open from January 2, 2004 to January 31, 2004 -Rallis India sells gelatine biz to Sterling Biotech Ltd -Rallis India inks pact with Dupont India Pvt Ltd on April 5, 2004, for insecticide marketing -Rallis India Ltd has informed that the company and EI Dupont India Private Ltd on April 5, 2004 have entered into an agreement, whereby company will co-market Dupont's insecticide Indoxacarb and Dupont will co-market company's insecticide Acetamiprid. - Rallis India enters into marketing alliances with global players like Syngenta, Bayer and Dupont 2007 -Rallis India Ltd has appointed Mr. Veeramani Shankar as the Executive Director of the Company. 2008 - Rallis India Ltd has informed that Dr. V S Sohoni has been appointed as Additional Director on the Board of the Company with effect from March 01, 2008. 2009 - Rallis India Ltd has appointed Mr. R. Mukundan as Additional Director on the Board of the Company. --Registered Office of the Company has been shifted to 156/157, 15th Floor, Nariman Bhavan, 227, Nariman Point, Mumbai - 400 021 2010 - Company has inaugurated a new Metconazole plant at its factory in Ankleshwar, Gujarat - Rallis India Ltd Acquires Majority stake in Metahelix Life Sciences - Rallis India - Board approves Bonus Issue -Rallis India has given the Bonus in the Ratio of 1:2 2011 - Rallis India crosses sales figure of Rs 1,000 crore For the year ended March 31, 2011 - Company has commenced commercial production at its new manufacturing facility at Dahej SEZ, Gujarat. -Company has splits its Face value of Shares from Rs 10 to Re 1 2012 - Rallis India Acquires 22.8% Stake in Zero Waste Agro Organics Private Limited 2013 - Tata Quality Management Services awarded Company's Dahej unit under Promising Innovations Category for New Product Innovation - The Company received National Energy Conservation Award from Mr. Pranab Mukerjee (President of India) for winning under Chemical sector -The Company awarded as Winner of Golden Peacock Award for Eco-Innovation in Chemical Sector - Federation of Indian Chambers of Commerce & Industry (FICCI) awarded the Company as Product Innovator of the Year in Agro Sector -The Company has recommended final dividend of Rs. 1.30 per share (130%) to the shareholders of the Company. 2014 - Rallis India Ltd appointed Dr. Punita Kumar-Sinha as an Additional Non - Executive, Independent Director of the Company - The Company has recommended final dividend of Rs. 1.40 per share (140%) to the shareholders of the Company. - ICC awarded Certificate of Merit for Best Compliant Company for the Process Safety Code under Responsible Care - Dahej unit awarded National Safety Award - The Award was presented by Hon'ble Union Minister for Labour & Employment Shri Narendra Singh Tomar at Vigyan Bhavan, New Delhi 2015 -India's Most Trusted Brand Award, 2015 in Best Company category -CII EXIM prize for Business Excellence -Origin product has received Product Innovator of the Year in Agrochemicals Sector awarded by FICCI Chemicals & Petrochemicals Awards 2016 -Rallis India gets approval for Rs 200 cr project in Gujarat. -The Company has signed an Agreement for increasing its stake in its Subsidiary Zero Waste Agro - Organics Limited from 73.63% to 100%. Consequently, ZWAO and become a wholly owned subsidiary of the Company, on completion of the acquisition of the balance shares in ZWAOL. 2019 -The Company has considered and approved the proposal for the merger of Metahelix Life Sciences Limited ('Transferor Company'), a wholly owned subsidiary of the Company, with Rallis India Limited ('the Company' or 'Transferee Company') and their Shareholders and Creditors, under Sections 230 to 234 of the Companies Act, 2013 2023 -"Rallis India powers its hybrid seed production process with mobile app SeedSure." 2024 -Rallis India Limited achieve key Flavocide production milestone.

Read More

Parent Organisation

Rallis India Ltd.

Founded

23/08/1948

Managing Director

Dr.Gyanendra Shukla

NSE Symbol

RALLISEQ

FAQ

The current price of Rallis India Ltd is ₹ 235.26.

The 52-week high for Rallis India Ltd is ₹ 244.70 and the 52-week low is ₹ 234.00.

The market capitalization of Rallis India Ltd is currently ₹ 4575.08. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Rallis India Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Rallis India Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Rallis India Ltd shares.

The CEO of Rallis India Ltd is Dr.Gyanendra Shukla, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT